169 related articles for article (PubMed ID: 2541168)
1. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
[TBL] [Abstract][Full Text] [Related]
3. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
7. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates.
Perez-Schael I; Blanco M; Garcia D; White L; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ; Flores J
J Med Virol; 1994 Apr; 42(4):330-7. PubMed ID: 8046423
[TBL] [Abstract][Full Text] [Related]
9. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.
Midthun K; Pang LZ; Flores J; Kapikian AZ
J Clin Microbiol; 1989 Dec; 27(12):2799-804. PubMed ID: 2556433
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
13. Rotavirus specific breast milk antibody in two populations and possible correlates of protection.
Losonsky GA; D'Alessandra de Rimer H
Adv Exp Med Biol; 1991; 310():265-9. PubMed ID: 1667067
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
[TBL] [Abstract][Full Text] [Related]
15. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
Vesikari T; Kapikian AZ; Delem A; Zissis G
J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.
Rimer HC; Wasserman SS; Flores J; Pichichero ME; Losonsky GA
J Infect Dis; 1992 May; 165(5):826-30. PubMed ID: 1373753
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.
Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ
Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
[TBL] [Abstract][Full Text] [Related]
20. Tetravalent rhesus rotavirus vaccine in young infants.
Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
